All Respiratory articles
-
InformationCOVID-19 hub for community pharmacy
The Guidelines for Pharmacy team has produced the following directory of COVID-19 information and guidance for community pharmacy. Included on this page is a collection of key guidance and advice from PSNC, FIP, and NHS, as well as a list of information for specific groups from a range of professional bodies.
-
Information
COVID-19 hub for primary care
The Guidelines team has produced this directory of COVID-19 information and guidance for primary care. Included on this page is a collection of key guidance and advice from PHE and the NHS, as well as a list of information for specific groups from a range of professional bodies
-
News
Largest trial of amoxicillin for treating chest infections in children finds little effect
Amoxicillin for uncomplicated chest infections in children is unlikely to be clinically effective, a new study finds
-
NICE guideline
NICE obstructive sleep apnoea guideline
Covering the diagnosis and management of OSAHS, and the assessment of OHS and COPD–OSAHS overlap syndrome in people over 16
-
News
Difficulties in accessing cystic fibrosis medications
A survey of healthcare professionals and patients with cystic fibrosis reveals problems in prescribing and accessing medications
-
News
BTS clinical statement on occupational asthma open to public consultation
The British Thoracic Society (BTS) has produced a clinical statement on occupational asthma, which is now open to public review
-
News
New guidance on obstructive breathing disorders published by NICE
NICE guideline 202 covers investigation and management of obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s
-
NICE guideline
NICE bronchiolitis guideline
A brief summary of the NICE guideline on bronchiolitis in babies and children, including advice on when to refer, and 'red flags' for parents
-
Video
GOLD COPD 2021 summary tour
This Guidelines summary tour highlights the new recommendations in the GOLD 2021 report, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease
-
News
NHS prepares for rise in child respiratory infections
Respiratory infections have begun to rise in young children following low infection levels in response to COVID-19 restrictions
-
Independent professional body guideline
GINA strategy 2021: management of asthma
This Guidelines summary outlines recommendations for the management of asthma in adults, adolescents, and children aged 6–11
-
News
GINA updates global strategy for asthma management and prevention
The update to GINA’s 2021 report contains updated treatment recommendations, and new advice about COVID-19 and asthma
-
NICE guideline
NICE asthma guideline: chronic asthma management
A practical summary of NICE recommendations on managing chronic asthma in children, young people, and adults, including three management algorithms
-
NICE guideline
NICE asthma guideline: diagnosis and monitoring
A concise summary on the initial assessment, diagnosis, and monitoring of asthma in adults, young people, and children. Includes assessment algorithms
-
Independent professional body guideline
GOLD COPD 2021 strategy
A clear summary of GOLD’s 2021 strategy on COPD diagnosis, management, and prevention, including recommendations on COVID-19 and COPD
-
Hosted content
COPD: LAMA/LABA therapy—Real life case studies
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200015 V2.0 -
News
GOLD COPD report 2021 published
GOLD has published its annual report on chronic obstructive lung disease, used worldwide by healthcare experts
-
Hosted content
Why you might want to review patients with COPD receiving a LAMA
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200013 -
Hosted content
COPD: Have you done enough to implement guidelines?
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200012 -
Hosted content
Why use LAMA/LABAs as initial maintenance therapy in specific COPD patients?
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200011
